Transthyretin‐related hereditary (TTR) amyloidoses represent a clinically heterogeneous group of diseases associated with various point mutations of the TTR gene. We propose a molecular strategy for the diagnosis of this group of disorders.— Ferlini, A.; Fini, S.; Salvi, F.; Patrosso, M. C.; Vezzoni, P.; Forabosco, A. Molecular strategies in genetic diagnosis of transthyretinrelated hereditary amyloidosis. FASEB J. 6: 2864‐2866; 1992.
No takes yet. Share an insight, caveat, or question.
Ferlini et al. (1992) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: